Theratechnologies presents preliminary primary endpoint results from phase III ibalizumab trial May 25, 2016
Gilead's MAA for Odefsey single tablet regimen receives positive opinion for the treatment of HIV May 2, 2016
CytoDyn reports complete viral load suppression in ongoing PRO-140 monotherapy extension study April 20, 2016